B-Cell Depletion and Return in Participant Subgroups of the Phase 3 ULTIMATE I and II Studies of Ublituximab Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis

Drug Category: Array
Conference Category: Array
Lead Author: Fox E, et al.
Published Date: 26/10/2022
Download Link: /wp-content/uploads/2022/10/1055-TGTX-ECTRIMS-2022-B-Cell-Depletion-13Oct22a.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top